312-35-6Relevant articles and documents
1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
-
Page 8, (2010/02/06)
The present invention discloses radioligands of 9-arylsulfone of the formula (X) or a pharmaceutically acceptable salt or enantiomer thereof, which are useful in diagnosing depression, obesity and other CNS disorders.
1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position
-
, (2008/06/13)
The present invention are substituted 9-arylsulfone-1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles (X) and unsubstituted 9-arylsulfone-1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles (XI) such as the compound of EXAMPLE 13 which are useful in treating depression, obesity and other CNS disorders.
Potential antileprotic agents. I. Inhibition of a model mycobacterial system by diaryl sulfones
Colwell,Chan,Brown,DeGraw,Peters,Morrison
, p. 142 - 144 (2007/10/12)
The development of a new antileprotic agent poses particular problems in view of the fact that the etiological agent of human leprosy, Mycobacterium leprae, cannot be cultured in bacteriological media. However, a correlation has been observed between mini